|
|
Volumn 31, Issue 2, 2002, Pages 190-198
|
|
Criteria for the use of COX-2 inhibitors: Specificity, effect, indication and safety;Kriterien für den einsatz von COX-2-inhibitoren
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
ANTIARRHYTHMIC AGENT;
ANTICOAGULANT AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARBAMAZEPINE;
CELECOXIB;
CYCLOOXYGENASE 1 INHIBITOR;
CYCLOOXYGENASE 2 INHIBITOR;
DIAZEPAM;
DICLOFENAC;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
FLUCONAZOLE;
FUROSEMIDE;
IBUPROFEN;
IMIPRAMINE;
KETOCONAZOLE;
LITHIUM;
METHOTREXATE;
NABUMETONE;
NAPROXEN;
NEUROLEPTIC AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARACETAMOL;
PHENYTOIN;
RIFAMPICIN;
ROFECOXIB;
SEROTONIN UPTAKE INHIBITOR;
UNINDEXED DRUG;
CYCLOOXYGENASE 2;
ISOENZYME;
MEMBRANE PROTEIN;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PTGS2 PROTEIN, HUMAN;
BLOOD TOXICITY;
DRUG EFFECT;
DRUG INDICATION;
DRUG SAFETY;
DRUG SCREENING;
DRUG SPECIFICITY;
DYSPEPSIA;
GASTROINTESTINAL TOXICITY;
HUMAN;
OSTEOARTHRITIS;
RHEUMATOID ARTHRITIS;
SHORT SURVEY;
DRUG CONTRAINDICATION;
DRUG INTERACTION;
REVIEW;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DRUG INTERACTIONS;
HUMANS;
ISOENZYMES;
MEMBRANE PROTEINS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
|
|
EID: 0036215409
PISSN: 00483664
EISSN: None
Source Type: Journal
DOI: 10.1002/1615-1003(200203)31:2<190::AID-PAUZ190>3.0.CO;2-S Document Type: Short Survey |
|
Times cited : (1)
|
|
References (27)
|
